Aller au contenu principal
Profil bibliographique

Ying Feng Zheng

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

95Publications signalées
3386Citations signalées
4Affiliations récentes

Les institutions déclarées

Les domaines associés

Global Cancer Incidence and ScreeningCancer Risks and FactorsBreast Cancer Treatment StudiesLung Cancer Treatments and MutationsCancer survivorship and care

Les publications récentes

Accès ouvert 2026 article OpenAlex

Obstructive sleep apnea and cardiovascular disease in individuals with metabolic dysfunction‐associated fatty liver disease: A prospective cohort study

Haizhen Chen, Ying Feng Zheng, Zhigang Wu, Ningjian Wang et autres

Abstract Objective To assess the association between obstructive sleep apnea (OSA) risk levels and major cardiovascular disease (CVD) subtypes in individuals with metabolic dysfunction‐associated fatty liver disease (MAFLD). Methods This cohort study included 128,022 MAFLD participants from the UK Biobank without CVD …

cn, se (code pays fourni par la source)

1 citation Sleep research.
2026 article OpenAlex

(‐)‐Epigallocatechin‐3‐Gallate (EGCG) Regulates the Formation of Zein–Ovalbumin Heteroprotein Complex Coacervates

Min Huang, Jiayi Han, Hao Li, Junhao Lin et autres

Growing interest in sustainable nutrition has improved the importance of understanding the interactions between (‐)‐Epigallocatechin‐3‐gallate (EGCG), a polyphenol in green tea, and proteins for functional food development. In this study, we investigated the regulatory effects of EGCG on the aggregation behavior of …

cn (code pays fourni par la source)

0 citations ChemBioChem
Accès ouvert 2025 article OpenAlex

RETRACTED ARTICLE: Recent progress in the exploitation of anti-cancer small molecules targeting angiogenesis

Ying Feng Zheng, Hao Qiu, Ke Zhang, Xiang Ji et autres

Angiogenesis is pivotal for cancer growth and metastasis, as tumours rely on new blood vessels to progress and spread. Antiangiogenic drugs represent a crucial therapeutic strategy that combats cancer by both obstructing the development of new blood vessels and disrupting existing tumour-associated …

cn (code pays fourni par la source)

2 citations Journal of Enzyme Inhibition and Medicinal Chemistry
Accès ouvert 2025 article OpenAlex

Functional diversification of bornyl diphosphate synthase in Lauraceae: An evolutionary framework for borneol-oriented molecular breeding

Qing Ma, Tong Chen, Mei Yang, Wen Xu et autres

Borneol, a bicyclic monoterpenoid with many pharmacological bioactivities and industrial applications, is biosynthesized through bornyl diphosphate synthase (BPPS) belonging to terpene synthase b (TPS-b) clade. While terpenoids are widely distributed in Lauraceae, high-level borneol production is species-specific, characterizing a unique borneol chemotype …

cn (code pays fourni par la source)

3 citations Industrial Crops and Products
Accès ouvert 2025 article OpenAlex

Exploring syphilis activity for personalized treatment strategies in latent syphilis: a 2-year cohort study

Jia‐Wen Xie, Ya‐Wen Zheng, Shu-Hao Fan, Yinfeng Guo et autres

Background Relying simply on the stage of latent syphilis may lead to excessive treatment strategies. Utilizing nontreponemal immunoglobulin M (IgM) antibodies to assess syphilis activity and tailor treatment strategies may offer enhanced therapeutic advantages. Objectives To investigate whether nontreponemal IgM antibodies can …

cn (code pays fourni par la source)

0 citations Sexual Health
Accès ouvert 2025 article OpenAlex

Dual distal insertions drive pimarane-to-miltiradiene rearrangement with enhanced enzymatic activity

Jianing Liu, Jian Wang, Guanghong Cui, Haiyan Zhang et autres

Miltiradiene, the major biosynthetic precursor of abietane diterpenoid natural products, has downstream metabolic derivatives with a significant potential for pharmacologically development. The formation of the characteristic abietane skeleton is attained through the rearrangement of the C13 methyl group in the pimarane intermediate, …

cn (code pays fourni par la source)

0 citations BioDesign Research
2025 conference-abstract OpenAlex

Abstract 2961: AZD9592, an EGFR/cMET bispecific antibody-drug conjugate (ADC), demonstrates target-dependent efficacy in colorectal cancer (CRC) patient-derived xenograft (PDX) models

Ying Feng Zheng, Edward C. Rosfjord, Simon Christ, Stephanie Zalesak‐Kravec et autres

Abstract Background: AZD9592 is a bispecific ADC designed to target both epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition tyrosine kinase receptor (cMET), delivering a topoisomerase 1 inhibitor payload to tumor cells. Despite recent advances in ADC development for CRC, such as …

us, de (code pays fourni par la source)

4 citations Cancer Research
Accès ouvert 2025 article OpenAlex

Effects of monoclonal antibody daratumumab combined with ixazomib-based treatment regimen on survival of patients with relapsed/refractory multiple myeloma

Lang Peng, Jiawen He, Ying Feng Zheng, Qingfang Zeng

Background/Aim. Combination therapy with daratumumab and ixazomib has been previously used for the treatment of multiple myeloma (MM), but treatment outcomes of these drugs and safety have not yet been confirmed. The aim of the study was to assess the effects of …

cn (code pays fourni par la source)

0 citations Vojnosanitetski pregled
2024 conference-abstract OpenAlex

Abstract 2285: Mass spectrometry-based proteomics profiling reveals differential proteome composition in tumor and normal tissues, with implications for normalization

Ying Feng Zheng, Lindsay Olita, M.C. Nivens, Abby J. Chiang et autres

Abstract The composition of the proteome varies significantly across different tissues and disease states creating a challenge of how best to compare expression levels of each protein across these tissue types. Traditionally, a median approach to normalization has been used, but this …

us (code pays fourni par la source)

0 citations Cancer Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.